SG135186A1 - Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation - Google Patents

Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation

Info

Publication number
SG135186A1
SG135186A1 SG200705930-6A SG2007059306A SG135186A1 SG 135186 A1 SG135186 A1 SG 135186A1 SG 2007059306 A SG2007059306 A SG 2007059306A SG 135186 A1 SG135186 A1 SG 135186A1
Authority
SG
Singapore
Prior art keywords
glimepiride
glycosylphosphatidylinositol
insulin
induced
regulation
Prior art date
Application number
SG200705930-6A
Other languages
English (en)
Inventor
Guenter Mueller
Wendelin Frick
Rudolf Schneider
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of SG135186A1 publication Critical patent/SG135186A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG200705930-6A 2004-02-20 2005-02-16 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation SG135186A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04003897A EP1566447A1 (fr) 2004-02-20 2004-02-20 Règlement de la glycosylphospatidylinositol-spécifique phospholipase C induit par glimepiride et insuline

Publications (1)

Publication Number Publication Date
SG135186A1 true SG135186A1 (en) 2007-09-28

Family

ID=34707348

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200705930-6A SG135186A1 (en) 2004-02-20 2005-02-16 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation

Country Status (11)

Country Link
EP (2) EP1566447A1 (fr)
JP (3) JP5514395B2 (fr)
KR (1) KR101191676B1 (fr)
CN (1) CN1981048B (fr)
AT (1) ATE551430T1 (fr)
AU (1) AU2005215886B2 (fr)
BR (1) BRPI0507889A (fr)
CA (1) CA2556868C (fr)
IL (3) IL177257A (fr)
SG (1) SG135186A1 (fr)
WO (1) WO2005080587A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017207822A1 (fr) 2016-06-03 2017-12-07 Lonza Limited Bioréacteur à usage unique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244546B (it) * 1991-02-01 1994-07-15 Mediolanum Farmaceutici Spa Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica
US5519163A (en) * 1993-10-15 1996-05-21 Merck & Co., Inc. Inhibitors of phosphoinositide-specific phospholipase C
JPH07206887A (ja) * 1994-01-24 1995-08-08 Asahi Chem Ind Co Ltd 新規ホスホリパーゼc阻害物質am6211及びその製造法
EP1307567A2 (fr) * 2000-07-31 2003-05-07 Bayer Aktiengesellschaft Regulation d'une enzyme humaine de type phospholipase c a phosphatidylinositol specifique
EP1379235B1 (fr) * 2000-10-10 2006-12-20 University Of North Carolina At Chapel Hill Compositions et methodes permettant d'ameliorer la permeabilite paracellulaire des barrieres epitheliales et endotheliales

Also Published As

Publication number Publication date
IL177257A (en) 2010-12-30
ATE551430T1 (de) 2012-04-15
AU2005215886A1 (en) 2005-09-01
WO2005080587A3 (fr) 2006-12-28
EP1718757A2 (fr) 2006-11-08
IL177257A0 (en) 2006-12-10
KR20060131845A (ko) 2006-12-20
IL202544A (en) 2011-02-28
JP5514395B2 (ja) 2014-06-04
JP2007522811A (ja) 2007-08-16
WO2005080587A2 (fr) 2005-09-01
BRPI0507889A (pt) 2007-08-07
EP1718757B1 (fr) 2012-03-28
JP2011140492A (ja) 2011-07-21
EP1566447A1 (fr) 2005-08-24
AU2005215886B2 (en) 2010-07-22
CN1981048A (zh) 2007-06-13
JP5337825B2 (ja) 2013-11-06
IL202543A (en) 2013-02-28
CA2556868C (fr) 2013-10-15
CN1981048B (zh) 2014-06-18
KR101191676B1 (ko) 2012-10-18
CA2556868A1 (fr) 2005-09-01
JP2012135318A (ja) 2012-07-19

Similar Documents

Publication Publication Date Title
WO2005080551A3 (fr) Cellules souches
TW200616646A (en) Synthesis of boronic ester and acid compounds
MX356756B (es) Células madre pluripotentes en microportadores.
TW200736221A (en) Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor
TW200635174A (en) Systems and methods for regulating pre-charge current in a battery system
MY144672A (en) Inhibitors of cytosolic phospholipase a2
MXPA05013582A (es) Celda de combustible de oxido solido soportada en apilado.
DK1851815T3 (da) Fremgangsmåde til fremstilling af en brændselscellekatode
AR055964A1 (es) Levadura modificada geneticamente de la especie issatchenkia orientalis y especies estrechamente relacionadas y procesos de fermentacion con el uso de ellas
ATE464372T1 (de) Expansion erneuerbarer stammzellpopulationen
GB2477698B (en) Methods for conducting cellular assays
AU2003277795A1 (en) A method of production of (-)-(s)-3-(1-(dimethylamino)ethyl)phenyl-n-ethyl-n-methylcarbamate
HK1079765A1 (en) PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED ß-AMINO ALCOHOLS
DK2071216T3 (da) Superplastisk pakning, fortrinsvis til et system med elektrokemiske celler
RS20050207A (en) Novel bicyclic inhibitors of hormone sensitive lipase
WO2009089634A8 (fr) Couvercles pour piles électrochimiques et procédés associés
GB0208041D0 (en) Method of culturing animal cells
SG135186A1 (en) Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation
WO2006027310A3 (fr) Modulation du nombre de cellules vegetales
WO2010020647A3 (fr) Nouveau procédé pour identifier des composés utilisés dans le traitement et/ou la prévention de maladies associées à la perte osseuse
DE60324930D1 (de) Elektrolyt für brennstoffzelle
DK1915796T3 (da) Biologisk brændselscelle
ATE518263T1 (de) Brennstoffzellen-reaktionsmittel-strömungsfelde zur maximierung der planform-ausnutzung
BRPI0411653A (pt) anodo para bateria
AU2001252618A1 (en) Cell proliferation inhibitors